BDX
NYSE · Health Care
Becton Dickinson And Co
$183.00
+2.30 (+1.27%)
Financial Highlights (FY 2026)
Revenue
20.62B
Net Income
1.58B
Gross Margin
45.9%
Profit Margin
7.7%
Rev Growth
+5.0%
D/E Ratio
0.76
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 45.9% | 45.9% | 66.9% | 66.9% |
| Operating Margin | 11.7% | 10.6% | 14.9% | 15.8% |
| Profit Margin | 7.7% | 7.3% | 11.1% | 10.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 20.62B | 19.64B | 18.67B | 17.52B |
| Gross Profit | 9.46B | 9.01B | 12.49B | 11.72B |
| Operating Income | 2.42B | 2.08B | 2.78B | 2.77B |
| Net Income | 1.58B | 1.36B | 2.06B | 1.90B |
| Gross Margin | 45.9% | 45.9% | 66.9% | 66.9% |
| Operating Margin | 11.7% | 10.6% | 14.9% | 15.8% |
| Profit Margin | 7.7% | 7.3% | 11.1% | 10.8% |
| Rev Growth | +5.0% | +5.0% | -1.1% | +21.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 10.61B | 10.61B | 15.78B | 15.66B |
| Total Equity | 14.04B | 14.04B | 37.83B | 32.91B |
| D/E Ratio | 0.76 | 0.76 | 0.42 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 4.75B | 4.29B | 4.26B | 3.54B |
| Free Cash Flow | — | — | 1.84B | 1.83B |